Patents by Inventor Yoram Devary

Yoram Devary has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYPEPTIDES FOR USE IN THE TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES
    Publication number: 20240009277
    Abstract: The present disclosure provides methods, compositions and kits for use in preventing, treating, ameliorating or delaying the onset of at least one of a neurodegenerative disease, cognitive decline and any conditions or symptoms associated therewith as well as for improving at least one of cognitive function, short term memory, long term memory, learning function, glucose metabolism and glucose transport.
    Type: Application
    Filed: November 2, 2021
    Publication date: January 11, 2024
    Inventor: Yoram DEVARY
  • Endoplasmic reticulum stress as a predictive tool in cancer therapy and a combination therapy for the treatment of cancer
    Patent number: 11813305
    Abstract: Provided are methods, agents and kits for use in assessing the effect of treatment on cancer patients. Further provided is a combination therapy for reducing the administered standard of care doses of anti-cancer agents in treated cancer patients.
    Type: Grant
    Filed: January 25, 2021
    Date of Patent: November 14, 2023
    Assignee: IMMUNE SYSTEM KEY LTD.
    Inventors: Yoram Devary, Uziel Sandler
  • ENDOPLASMIC RETICULUM STRESS AS A PREDICTIVE TOOL IN CANCER THERAPY AND A COMBINATION THERAPY FOR THE TREATMENT OF CANCER
    Publication number: 20210154262
    Abstract: Provided are methods, agents and kits for use in assessing the effect of treatment on cancer patients. Further provided is a combination therapy for reducing the administered standard of care doses of anti-cancer agents in treated cancer patients.
    Type: Application
    Filed: January 25, 2021
    Publication date: May 27, 2021
    Applicant: IMMUNE SYSTEM KEY LTD.
    Inventors: Yoram DEVARY, Uziel SANDLER
  • Endoplasmic reticulum stress as a predictive tool in cancer therapy and a combination therapy for the treatment of cancer
    Patent number: 10933117
    Abstract: Provided are methods, agents and kits for use in assessing the effect of treatment on cancer patients. Further provided is a combination therapy for reducing the administered standard of care doses of anti-cancer agents in treated cancer patients.
    Type: Grant
    Filed: July 31, 2018
    Date of Patent: March 2, 2021
    Assignee: IMMUNE SYSTEM KEY LTD.
    Inventors: Yoram Devary, Uziel Sandler
  • A METHOD OF SENSITIZING CANCER CELLS TO ANTI-CANCER TREATMENT
    Publication number: 20200115413
    Abstract: A combinational therapy for treatment of cancer. Compositions, methods and kits for treatment of cancer and for sensitizing cancer cells to a broad spectrum of anti-cancer agents.
    Type: Application
    Filed: May 17, 2018
    Publication date: April 16, 2020
    Inventor: Yoram DEVARY
  • ENDOPLASMIC RETICULUM STRESS AS A PREDICTIVE TOOL IN CANCER THERAPY AND A COMBINATION THERAPY FOR THE TREATMENT OF CANCER
    Publication number: 20180333452
    Abstract: Provided are methods, agents and kits for use in assessing the effect of treatment on cancer patients. Further provided is a combination therapy for reducing the administered standard of care doses of anti-cancer agents in treated cancer patients.
    Type: Application
    Filed: July 31, 2018
    Publication date: November 22, 2018
    Applicant: IMMUNE SYSTEM KEY LTD.
    Inventors: Yoram DEVARY, Uziel SANDLER
  • Pharmaceutical compositions and methods for the treatment of metastatic cancer
    Patent number: 9878015
    Abstract: The invention provides isolated peptides, fragments and derivatives thereof and pharmaceutical compositions comprising same that are useful for the prevention or treatment of cancer metastasis.
    Type: Grant
    Filed: December 4, 2014
    Date of Patent: January 30, 2018
    Assignee: IMMUNE SYSTEM KEY LTD.
    Inventors: Yoram Devary, Uziel Sandler
  • PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF METASTATIC CANCER
    Publication number: 20160303200
    Abstract: The invention provides isolated peptides, fragments and derivatives thereof and pharmaceutical compositions comprising same that are useful for the prevention or treatment of cancer metastasis.
    Type: Application
    Filed: December 4, 2014
    Publication date: October 20, 2016
    Inventors: Yoram DEVARY, Uziel SANDLER
  • Thymus-specific protein
    Patent number: 8071716
    Abstract: The invention provides the novel thymus-specific human protein T101, an 84-amino acid polypeptide isolated from the human thymus. The full T101 peptide contains a 33-amino acid signal peptide and a 51-amino acid T101 peptide sequence with both immune stimulatory and inhibitory activities. Also provided are modified peptides and partial T101 peptide sequences.
    Type: Grant
    Filed: October 26, 2005
    Date of Patent: December 6, 2011
    Assignee: Immune System Key Ltd.
    Inventors: Yoram Devary, Uziel Sandler
  • THERAPEUTIC METHODS USING A THYMUS PEPTIDE
    Publication number: 20100204097
    Abstract: A method for treating or preventing a disease involving a cell having a T1/ST2 receptor, including administering to subject in need thereof a therapeutically effective amount of a thymic peptide, is provided. Also provided is a method for inhibiting the pathological effects of activated monocytes in a subject in need thereof including treating the monocytes with an effective amount of the thymic peptide.
    Type: Application
    Filed: December 18, 2007
    Publication date: August 12, 2010
    Applicant: IMMUNE SYSTEM KEY LTD.
    Inventors: Yoram Devary, Uziel Sandler
  • Thymus-specific protein
    Publication number: 20090018060
    Abstract: The invention provides the novel thymus-specific human protein T101, an 84-amino acid polypeptide isolated from the human thymus. The full T101 peptide contains a 33-amino acid signal peptide and a 51-amino acid T101 peptide sequence with both immune stimulatory and inhibitory activities. Also provided are modified peptides and partial T101 peptide sequences.
    Type: Application
    Filed: October 26, 2005
    Publication date: January 15, 2009
    Applicant: IMMUNE SYSTEM KEY LTD.
    Inventors: Yoram Devary, Uziel Sandler